FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to veterinary science, namely to virology and biotechnology. The vaccine contains avirulent and purified antigen material of the foot-and-mouth disease type A virus strain No. 2171/Kabardino-Balkarian/2013 prepared in the passaged cell culture VNK-21, representing a suspension primarily containing 146S and 75S immunogenic components of the foot-and-mouth disease, the adjuvants aluminium hydroxide with saponin and a maintenance medium in effective ratios.
EFFECT: vaccine possesses the high immunogeneicity and is able to provide the effective protection against the homologous agent of the infection persistent in Transcaucasus, Central Asia, Middle and Near East.
11 cl, 7 ex, 8 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| INACTIVATED SORPTIVE VACCINE TO FMD TYPES A, O, ASIA-1 | 2015 |
|
RU2603003C1 |
| INACTIVATED SORPTIVE FOOT-AND-MOUTH DISEASE TYPE A VACCINE | 2017 |
|
RU2681815C1 |
| FOOT-AND-MOUTH DISEASE VIRUS STRAIN Aphtae epizooticae TYPE A FOR PRODUCING AND CONTROLLING BIOLOGICAL PREPARATION FOR DIAGNOSTICS AND SPECIFIC PREVENTION OF TYPE A FOOT-AND-MOUTH DISEASE | 2014 |
|
RU2560268C1 |
| INACTIVATED SORBED VACCINE AGAINST FMD OF TYPE A | 2014 |
|
RU2563345C1 |
| INACTIVATED EMULSION VACCINE AGAINST FOOT-AND-MOUTH DISEASE TYPES A, O, ASIA-1 | 2015 |
|
RU2593718C1 |
| INACTIVATED SORBENT TYPE A FOOT-AND-MOUTH DISEASE VACCINE | 2012 |
|
RU2526570C2 |
| STRAIN A №2166/KRASNODARSKIY/2013 MURRAIN VIRUS APHTAE EPIZOOTICAE TYPE A FOR ANTIGENIC AND IMMUNOGENIC ACTIVITY AND TO PRODUCE BIOPREPARATIONS FOR DIAGNOSIS AND SPECIFIC PREVENTION OF MURRAIN TYPE A | 2015 |
|
RU2604200C9 |
| A N2269/VNIIZZH/2015 STRAIN OF TYPE A APHTAE EPIZOOTICAE FOOT-AND-MOUTH DISEASE VIRUS FOR CONTROL OF ANTIGENIC AND IMMUNOGENIC ACTIVITY AND FOR MANUFACTURE OF BIOPREPARATIONS FOR DIAGNOSIS AND SPECIFIC PREVENTION OF TYPE A FOOT-AND-MOUTH DISEASE | 2016 |
|
RU2640261C1 |
| A 2045/KYRGYZSTAN/ 2007 STRAIN OF FOOT-AND-MOUTH DISEASE VIRUS Aphtae epizooticae TYPE A FOR ANTIGENIC AND IMMUNOGENIC PERFORMANCE CONTROL OF FOOT-AND-MOUTH DISEASE VACCINES AND FOR PRODUCTION OF BIOPREPARATIONS FOR DIAGNOSIS AND SPECIFIC PREVENTION OF FOOT-AND-MOUTH DISEASE TYPE A | 2010 |
|
RU2451745C2 |
| INACTIVATED EMULSION VACCINE AGAINST FOOT-AND-MOUTH DISEASE TYPE A | 2017 |
|
RU2665850C1 |
